Navigation Links
Looking into a fly's eyes
Date:12/6/2012

This press release is available in German.

Fine venules, thin branches of nerve tracts - thanks to the ultramicroscope developed at the Bioelectronics Department of the Institute for Solid-State Electronics at the Vienna University of Technology, the tiniest details of biological tissues can be represented in 3D. Laser beams are used to look inside flies, mice, or medical tissue samples. The laser technology and the optics in the device were developed by Saideh Saghafi. Using various optical tricks, she has managed to turn a laser beam into an extremely thin two-dimensional laser surface, which can be shone through samples layer by layer. She has now been awarded a major optics prize for this work.

Tissue made transparent

Biological tissue tends to be opaque, with light being scattered at the interfaces between different materials. This is why we cannot see through thick fog: each individual floating droplet of fog scatters the light, so all we can see is a blanket of white.

In order to represent the internal structure of biological tissue, it must first be made transparent to laser beams. 'The sample is treated first of all: any water it contains is replaced with a fluid with different optical properties, and this enables laser beams to penetrate deep into the sample,' explains Saideh Saghafi. Together with her colleagues at the department of Prof. Hans Ulrich Dodt at the Vienna University of Technology, she is creating images of previously unmatched quality, which are providing important information for medical research. The novel ultramicroscope is also ideal for the investigation and 3D representation of human tumours from a pathology perspective.

Ultra-thin light surfaces

Optical tricks are initially used to convert a conventional round laser beam into an elliptical beam, which is transforme
'/>"/>

Contact: Florian Aigner
florian.aigner@tuwien.ac.at
43-158-801-41027
Vienna University of Technology
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Leaner Navy looking at future technology, fleet size and sequestration
2. Looking for the next American hyrax?
3. Better looking birds have more help at home with their chicks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Looking into a fly's eyes
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
(Date:12/5/2014)... 2014  Tute Genomics, a leader in cloud-based solutions ... A1 funding led by UK-based Eurovestech. Peak Ventures and ... investment round. "We are at a pivotal ... sequencing and seeks new approaches for the diagnosis, treatment ... MD MBA, and CEO of Tute Genomics. "One of ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... University researchers have received a $1.5 million federal ... account of their ecological footprint., Seven researchers in ... Resources, Biosystems Engineering, and USDA Agricultural Research Service ... elements central to farming and out of balance ...
... purification of drug components is a large hurdle facing ... that utilize proteins, which are notoriously difficult to separate ... for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic ... and improve an important protein purification process. ...
... new class of drug designed to target the hepatitis ... some of the HCV strains being treated exhibited signs ... of Florida State University biologists, chemists and biomedical researchers ... the drug-resistant HCV strains and the molecular-level mechanisms that ...
Cached Biology News:WSU researchers taking sustainability of organic farming to new level 2Purifying proteins: Rensselaer researchers use NMR to improve drug development 2Purifying proteins: Rensselaer researchers use NMR to improve drug development 3Hepatitis C virus faces new weapon from Florida State scientists 2Hepatitis C virus faces new weapon from Florida State scientists 3
(Date:12/24/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... Shandong Taibang Biological Products Co. Ltd., has received ... Food and Drug Administration (the "CFDA") for its ... in the Company,s public filings, the CFDA inspected ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
(Date:12/22/2014)... 22, 2014 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, announced ... University of Calgary in conjunction with co-authors from Kyoto ... validates the company,s ongoing clinical research using dermal sheath ... baldness. The paper entitled " Hair Follicle ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Reports Financial Results for the 12 Months Ended December ... A/S,(OMX: GEN) announced today results for the financial year ... (approximately USD 104 million) compared to,DKK 136 million (approximately ... of DKK 437 million (approximately USD 86 million).,This compares ...
... (OTC Bulletin Board: IMYN), a biotechnology firm that ... to,the biopharmaceutical SF-1019, has announced its results for ... the year ended December 31, 2007, the company ... in interest expense which,was funded from advances by ...
... Elbit Imaging Ltd.,(Nasdaq: EMITF ) ("EI" or ... year 2007., Transition to IFRS, Through ... been,prepared in accordance with generally accepted accounting principles ... provisions of Standard 29 of the Israeli,Accounting Standard ...
Cached Biology Technology:Genmab Announces Year End 2007 Financial Results 2Genmab Announces Year End 2007 Financial Results 3Genmab Announces Year End 2007 Financial Results 4Genmab Announces Year End 2007 Financial Results 5Immunosyn Corporation Announces 2007 Results, Files 10KSB 2Immunosyn Corporation Announces 2007 Results, Files 10KSB 3Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 2Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 3Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 4Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 5Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 6Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 7Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 8Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 9Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 10Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 11Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 12Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 13Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 14Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 15Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 16
GEL FILTRATION CAL KIT HMW, 1 EA. *Category: Gel Filtration Gels....
Mouse monoclonal [6C3] to JAB1 ( Abpromise for all tested applications). entrezGeneID: 10987 SwissProtID: O15386...
Human TGF-beta RIIb Affinity Purified Polyclonal Ab...
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
Biology Products: